Nuwellis, Inc., a medical device company, focuses on the development, manufacture and marketing of medical devices used in ultrafiltration therapy. The company is headquartered in Eden Prairie, Minnesota.
| Revenue (TTM) | $8.77M |
| Gross Profit (TTM) | $5.74M |
| EBITDA | $-12.25M |
| Operating Margin | -181.70% |
| Return on Equity | -584.00% |
| Return on Assets | -109.50% |
| Revenue/Share (TTM) | $7.41 |
| Book Value | $1.09 |
| Price-to-Book | 1.05 |
| Price-to-Sales (TTM) | 0.32 |
| EV/Revenue | 0.112 |
| EV/EBITDA | -0.34 |
| Quarterly Earnings Growth (YoY) | -99.20% |
| Quarterly Revenue Growth (YoY) | 26.20% |
| Shares Outstanding | $2.68M |
| Float | $2.61M |
| % Insiders | 0.98% |
| % Institutions | 11.06% |
Volatility is currently contracting